Cy3-UTP ÒÖÖÆ¼Á BMPO Leukotriene D4 Ó«¹âȾÁÏ DMAPP ¶¨ÖƺϳÉ
Sodium dodecyl sulfateÖÐÎıðÃû£ºÊ®¶þÍé»ùÁòËá | Ô¹ð»ùÁòËáÄÆ | Ô¹ð»ùÁòËáÄÆ | ÕýÊ®¶þÍé»ùÁòËáÄÆ
1¡¢Ê®¶þÍé»ùÁòËáÄÆÓÃ;£º
¡¾ÓÃ;һ¡¿ ÓÃ×÷Ï´µÓ¼ÁºÍ·ÄÖ¯Öú¼Á£¬Ò²ÓÃ×÷ÑÀ¸àÆðÅݼÁ¡¢¿ó¾®Ãð»ð¼Á¡¢ÈéÒº¾ÛºÏÈ黯¼Á¡¢Ñò뾻ϴ¼ÁµÈ
¡¾ÓÃ;¶þ¡¿ ÓÃ×÷ÒõÀë×ÓÐͱíÃæ»î»¯¼Á¡¢È黯¼Á¼°·¢ÅݼÁ ¡¾ÓÃ;Èý¡¿ GB 2760-96¹æ¶¨ÎªÊ³Æ·¹¤ÒµÓüӹ¤Öú¼Á¡£·¢ÅݼÁ£»È黯¼Á£»ÒõÀë×ÓÐͱíÃæ»îÐÔ¼Á¡£ÓÃÓÚµ°¸â¡¢ÒûÁÏ¡¢µ°°×¡¢Ïʹû¡¢¹ûÖÒûÁÏ¡¢Ê³ÓÃÓ͵ȡ£ ¡¾ÓÃ;ËÄ¡¿ ÓÃ×÷Ò©Îï¡¢»¯×±Æ·¡¢ºÏ³ÉÊ÷Ö¬µÄÈ黯¼Á¡£ÑÀ¸à¡¢Ãð»ðÆ÷µÄ·¢ÅݼÁ¡£ÓÃ×÷˿ëÀྫƷ֯ÎïµÄÏ´µÓ¼Á¡£½ðÊôÑ¡¿óµÄ¸¡Ñ¡¼Á¡£ ¡¾ÓÃ;Îå¡¿ ÓÃ×÷Ï´µÓºÍ·ÄÖ¯Öú¼Á£¬Ò²ÓÃ×÷ÑÀ¸à·¢ÅݼÁ£¬Ãð»ðÅÝÄÒº£¬ÈéÒº¾ÛºÏÈ黯¼Á£¬Ò½Ò©ÓÃÈ黯·ÖÉ¢¼Á£¬Ï´·¢¼ÁµÈ»¯×±ÖÆÆ·£¬Ñò뾻ϴ¼Á¡£ ¡¾ÓÃ;Áù¡¿ Éú»¯·ÖÎö£¬µçÓ¾£¬Àë×Ó¶ÔÊÔ¼Á
2¡¢Ê®¶þÍé»ùÁòËáÄÆÎïÀí²ÎÊý£º
³£ÓÃÃû
Ê®¶þÍé»ùÁòËáÄÆ
Ó¢ÎÄÃû
sodium dodecyl sulfate
CASºÅ
151-21-3
·Ö×ÓÁ¿
288.379
ÃܶÈ
0.25g/ml
·Ðµã
ÎÞ×ÊÁÏ
·Ö×Óʽ
C12H25NaO4S
ÈÛµã
206?C
ÉÁµã
>100?C
3¡¢Ê®¶þÍé»ùÁòËáÄÆÉú̬ѧÊý¾Ý£º
ÆäËüÓк¦×÷Ó㺸ÃÎïÖʶԻ·¾³¿ÉÄÜÓÐΣº¦£¬¶ÔË®ÌåÓ¦¸øÓèÌØ±ð×¢Òâ¡£´óÊó¾¿ÚLD50:1300mg/kg£¬Óã°ëÖÂËÀÁ¿£¨TML£©24.5¡Á10£6¡£
4¡¢Ê®¶þÍé»ùÁòËáÄÆÐÔÖÊÓëÎȶ¨ÐÔ£º
1.³£Î³£Ñ¹ÏÂÎȶ¨¡£
½ûÅäÎǿÑõ»¯¼Á
2.Ò×ÈÜÓÚË®£¬¶ÔËá¡¢¼îºÍӲˮÎȶ¨£»Ò×Îü³±½á¿é£»ÈÜÓÚË®£¬¶Ô¼îºÍӲˮ²»Ãô¸Ð¡£·Û×´µÄK12Ò×ÎüË®½á¿é¡£ÓÐÈ¥ÎÛ¡¢È黯¼°ÓÅÒìµÄ·¢ÅÝ×÷Óã¬ÉúÎï½µ½âÐԺá£
3.¾ßÓнÏÇ¿µÄÈ¥ÎÛ¡¢ÉøÍ¸¡¢Èóʪ¡¢·¢ÅÝ¡¢È黯¡¢·ÖÉ¢µÈÐÔÄÜ¡£
4.¶Ôð¤Ä¤ºÍÉϺôÎüµÀ¼°ÑÛºÍÆ¤·ôÓд̼¤×÷Ó᣿ÉÒýÆðºôÎüϵͳ¹ýÃôÐÔ·´Ó¦
5¡¢Ê®¶þÍé»ùÁòËáÄÆÖü´æ·½·¨£º
ËÜÁÏͰװ»òÄÚ³ÄËÜÌúͰװ¡£Öü´æÓÚÒõÁ¹¸ÉÔï´¦¡£
6¡¢Í¬Àà²úÆ·ÁÐ±í£º
Æ·ÅÆ
»õºÅ
ÖÐÎÄÃû³Æ
Ó¢ÎÄÃû³Æ
CAS
°ü×°
´¿¶È
MedBio
MED21606
(S)-Glycyl-H-1152 (hydrochloride)(solution)
913844-45-8
10mg (solution)
¡Ý98%
MED22443
N-Glycyl-L-tyrosine
658-79-7
50mg
MED21025
15-Lipoxygenase Inhibitor 1
928853-86-5
500ug
MED20519
N-(Benzoyloxy)succinimide
23405-15-4
1g
MED22182
¦Ã-Linolenoyl Ethanolamide(solution)
150314-37-7
MED20348
Zerumbone
471-05-6
10mg
MED22755
3-methyladipate
3058-01-3
MED21750
PtdIns-(1,2-dioctanoyl) (sodium salt)
899827-36-2
MED21825
Gestrinone
16320-04-0
MED22263
Lutein
127-40-2
1mg
7¡¢Ê®¶þÍé»ùÁòËáÄÆÎÄÏ×£º
Salicylic acid signaling controls the maturation and localization of the arabidopsis defense protein ACCELERATED CELL DEATH6. Mol. Plant 7(8) , 1365-83, (2014)
Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis. Cancer Res. 75(6) , 1102-12, (2015)
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. Nat. Commun. 6 , 5794, (2015)
8¡¢Ê®¶þÍé»ùÁòËáÄÆÓ¢ÎıðÃû£º
021-69568360
ÖÜÒ»ÖÁÖÜÎ壺8:30-17:30
¹ú¼Ò·¨¶¨½Ú¼ÙÈÕ³ýÍâ
±¾ÍøÕ¾ÏúÊÛµÄËùÓвúÆ·½öÓÃÓÚ¿ÆÑеȷÇÒ½ÁÆÓÃ;£¬·ÇÒ©Æ·²»¿ÉʳÓ㬲»¿ÉÓÃÓÚÈËÌå»ò¶¯ÎïµÄÁÙ´²Õï¶ÏºÍÖÎÁÆ¡£ÎÒÃDz»Îª¸öÈËÌṩ²úÆ·¼°·þÎñ¡£
Copyright © 2020-2025 MedBio All Rights Reserved ÉϺ£Âö²¬Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾
Ñϸñ½ûÖ¹ÔÚδ¾Í¬ÒâµÄÇé¿öÏÂ×ªÔØ±¾ÍøÕ¾Ö®ËùÓÐÐÅÏ¢¡£ÈçÐèÊÚȨ£¬ÇëÁªÏµÎÒ˾¡£
»¦¹«Íø°²±¸ 31011402010197ºÅ | | »¦ICP±¸2020034979ºÅ
MedBio¿Í·þ1
MedBio¿Í·þ2
MedBio¿Í·þ3
MedBio¿Í·þ4
MedBio¿Í·þ5
MedBio¿Í·þ6
400-186-1816